Delic Holdings Corp. (DELCF) Stock

About Delic Holdings Corp.

Delic Holdings Corp. (DELCF) provides a range of medical services and treatments across the United States and Canada. The company manages several key initiatives, including "The Delic," an innovative creative platform designed to facilitate public discussions about psychedelic culture. It also orchestrates "Meet Delic" events, which delve into vital subjects such as safety protocols, harm reduction, the interplay of psychedelics with mental health and the entertainment industry, personal integration, human performance enhancement, and various medical applications. Furthermore, Delic operates "Reality Sandwich," a comprehensive online educational hub offering approximately 10,000 pieces of content, encompassing psychedelic guides, current news, and cultural insights. Its "Delic Radio" podcast features expert-led conversations on topics spanning psychedelic news, scientific research, cultural implications, therapeutic uses, current affairs, and policy. Beyond its media platforms, Delic Holdings is actively engaged in developing intellectual property through dedicated research and development efforts in both the cannabis and psychedelic sectors. The company also owns and operates a total of fifteen ketamine infusion treatment clinics. Delic Holdings Corp. maintains its headquarters in Vancouver, Canada.

Delic Holdings Corp. (DELCF) stock trades at $0.00 with a market capitalization of $8803. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Delic Holdings Corp. generates a return on equity (ROE) of -81.82%, return on capital employed of -47.55%, an operating margin of -300.00%, a net profit margin of -450.00%.

Official website: deliccorp.com